Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $91.03 | $17.24 | 427.98% | 379.29x | 27.40x | 27.81x | 74.56x | 1.84x | $41.15M | 0.51% | $108.58M | 1.23 | $8.05B | 150.34 | ||
| CORT | CORCEPT THERAPEUTICS INC | $114.23 | $24.80 | 360.61% | 215.53x | 195.80x | 14.49x | 17.50x | 1.67x | $106.92M | 0.89% | $705.78M | 6.70 | $12.25B | 1,561.05 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $216.98 | $95.61 | 126.94% | 35.57x | 29.95x | 6.03x | 21.44x | 1.08x | $793.95M | 2.74% | $1.35B | 10.14 | $30.31B | 25.70 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.92 | $8.39 | 208.83% | 123.43x | 161.09x | 7.29x | 14.77x | 1.14x | $39.15M | 1.16% | $220.58M | 1.69 | $3.34B | 73.53 | ||
| RPRX | ROYALTY PHARMA PLC | $57.97 | $38.92 | 48.95% | 30.84x | 10.80x | 10.17x | 3.41x | 0.64x | $2.92B | 11.33% | $9.79B | 21.99 | $41.48B | 35.27 | ||
| ASND | ASCENDIS PHARMA A | $255.62 | $77.05 | 231.75% | 27.09x | 17.58x | 15.59x | 27.66x | 2.82x | $52.94M | 0.33% | $574.09M | 9.24 | $16.26B | 174.34 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.53 | $16.60 | 361.09% | 71.52x | 60.79x | 7.06x | 9.13x | 2.21x | $182.84M | 3.08% | $654.15M | 8.43 | $5.80B | 48.39 | ||
| KRYS | KRYSTAL BIOTECH INC | $331.59 | $87.27 | 279.94% | 40.10x | 43.48x | 22.23x | 7.22x | 2.36x | $257.78M | 2.63% | $1.36B | 46.03 | $9.40B | 40.28 | ||
| ADMA | ADMA BIOLOGICS INC | $9.75 | $8.83 | 10.45% | 13.54x | 11.62x | 4.34x | 5.35x | 0.61x | $116.47M | 5.23% | $408.21M | 1.79 | $2.25B | 9.64 | ||
| HALO | HALOZYME THERAPEUTICS INC | $102.62 | $71.63 | 43.27% | 28.83x | 12.36x | 7.23x | 81.14x | 0.62x | $806.22M | 6.70% | $143.54M | 1.22 | $13.63B | 18.97 | ||
| VCEL | VERICEL CORP | $43.95 | $8.98 | 389.20% | 91.56x | 91.16x | 7.33x | 6.08x | 2.17x | $61.66M | 2.75% | $370.04M | 7.25 | $2.22B | 50.35 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $68.88 | $21.46 | 220.98% | 181.26x | 18.54x | 3.91x | 2.11x | 1.14x | $738.18M | 5.54% | $6.32B | 32.68 | $16.65B | 43.16 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.48 | $9.54 | 20.30% | 12.08x | 11.09x | 4.99x | 3.13x | 0.78x | $82.01M | 12.07% | $217.65M | 3.68 | $537.90M | 6.96 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.05 | $2.26 | 34.89% | 15.25x | 13.19x | 1.87x | 2.92x | 0.79x | $5.67M | 2.36% | $82.53M | 1.04 | $176.92M | 9.47 | ||
| TGTX | TG THERAPEUTICS INC | $49.16 | $24.10 | 103.94% | 15.96x | 34.89x | 8.72x | 12.46x | 1.87x | $17.39M | 0.25% | $604.08M | 4.26 | $7.79B | 55.98 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $295.70 | $94.38 | 213.31% | 29.36x | 32.00x | 20.42x | 6.09x | 2.20x | $130.62M | 2.20% | $967.52M | 48.22 | $6.02B | 21.58 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $256.52 | $196.86 | 30.30% | 16.81x | 9.94x | 3.52x | 3.47x | 0.69x | $1.62B | 9.99% | $4.80B | 75.98 | $19.43B | 12.02 | ||
| TECH | BIO-TECHNE CORP | $72.12 | $16.11 | 347.73% | 101.58x | 34.57x | 9.31x | 5.41x | 1.86x | $269.60M | 2.39% | $2.09B | 13.34 | $11.37B | 44.43 | ||
| MDXG | MIMEDX GROUP INC | $4.27 | $1.12 | 281.78% | 106.75x | -38.06x | 1.78x | 2.88x | 1.51x | $44.50M | 7.05% | $216.00M | 1.46 | $503.76M | 22.09 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.23 | $8.64 | -85.76% | 4.56x | -4.16x | 1.15x | 1.35x | 0.05x | $7.24M | 10.24% | $52.93M | 0.92 | $17.56M | 1.13 | ||
| UTHR | UNITED THERAPEUTICS CORP | $529.66 | $225.74 | 134.63% | 17.52x | 19.35x | 7.15x | 20.28x | 2.36x | $1.09B | 4.84% | $6.40B | 150.24 | $127.96B | 76.33 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $808.05 | $418.95 | 92.88% | 19.27x | 17.30x | 5.35x | 2.62x | 1.26x | $3.76B | 4.53% | $31.71B | 308.48 | $83.44B | 14.51 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $523.91 | $158.64 | 230.25% | 30.23x | 27.09x | 10.56x | 6.56x | 2.39x | $3.80B | 2.86% | $20.25B | 79.81 | $128.62B | 23.37 | ||
| EXEL | EXELIXIS INC | $52.96 | $28.70 | 84.50% | 16.10x | 16.46x | 5.45x | 7.12x | 1.42x | $1.17B | 8.83% | $1.84B | 7.35 | $13.01B | 11.96 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.00 | $33.12 | 17.77% | 12.42x | 10.27x | 2.35x | 2.27x | 0.73x | $354.90M | 15.71% | $999.24M | 17.25 | $1.88B | 6.70 | ||
| INCY | INCYTE CORP | $121.55 | $60.76 | 100.05% | 14.97x | 15.99x | 4.19x | 3.88x | 2.00x | $1.92B | 7.88% | $6.34B | 31.66 | $20.69B | 10.00 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.